Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection: A Synergy of Novel Biomarkers, Advanced Imaging, and Robotic-assisted Diagnosis

NCT05443412 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT05443412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05443412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection: A Synergy of Novel Biomarkers, Advanced Imaging, and Robotic-assisted Diagnosis
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2023
Completion date
October 30, 2026
Enrollment
510 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer